Top Markets
Coin of the day
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
Rank in Stocks #7949
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
Share Price
$3.11
Market Cap
$1.41B
Change (1 day)
-1.97%
Change (1 year)
-57.22%
Country
CN
Trade Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

Category

Stock price history for Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)
Highest end of day price: $3.38 on 2026-08-01

Lowest end of day price: $1.01 on 2011-04-01
Stock price history of Staidson (Beijing) BioPharmaceuticals Co., Ltd. from 2011 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 5.61%
2025 251.84%
2024 -26.03%
2023 -29.22%
2022 -22.33%
2021 84.25%
2020 -2.73%
2019 -4.89%
2018 -25.27%
2017 -17.93%
2016 -37.14%
2015 89.87%
2014 4.94%
2013 1.98%
2012 47.53%
2011 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$542.09 38.27%
US
$1.03K 45.80%
NL
$121.53 -12.48%
AU
$138.18 464.67%
US
$759.27 6.90%
CH